• Explore /
  • Poster
  • / Macrophage polarization related gene variants to predict clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with bevacizumab (bev) in combination with FOLFIRI.

Macrophage polarization related gene variants to predict clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with bevacizumab (bev) in combination with FOLFIRI.

Abstract Poster

Authors

Yu Sunakawa

Yu Sunakawa

University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

Yu Sunakawa , Sebastian Stintzing , Volker Heinemann , Fotios Loupakis , Chiara Cremolini , Shu Cao , Dongyun Yang , Wu Zhang , Anish Parekh , Shinichi Yamauchi , Yan Ning , Stefan Stremitzer , Satoshi Matsusaka , Angela Mendez , Rita Elie El-Khoueiry , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 621)

DOI

10.1200/jco.2015.33.3_suppl.621

Abstract #

621

Poster Bd #

C13

Abstract Disclosures

Similar Posters

First Author: Yu Sunakawa

First Author: Hiroyuki Arai

First Author: Yu Sunakawa

First Author: Federico Innocenti